- Home
- SCYX vs CAPT Comparison
SCYX vs CAPT Comparison
Compare SCYX & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- CAPT
- Stock Information
- Founded
- SCYX 1999
- CAPT 2005
- Country
- SCYX United States
- CAPT South Korea
- Employees
- SCYX N/A
- CAPT N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- CAPT Blank Checks
- Sector
- SCYX Health Care
- CAPT Finance
- Exchange
- SCYX Nasdaq
- CAPT Nasdaq
- Market Cap
- SCYX 34.9M
- CAPT 37.9M
- IPO Year
- SCYX 2014
- CAPT N/A
- Fundamental
- Price
- SCYX $0.83
- CAPT $1.29
- Analyst Decision
- SCYX
- CAPT
- Analyst Count
- SCYX 0
- CAPT 0
- Target Price
- SCYX N/A
- CAPT N/A
- AVG Volume (30 Days)
- SCYX 167.5K
- CAPT 158.7K
- Earning Date
- SCYX 08-13-2025
- CAPT 01-01-0001
- Dividend Yield
- SCYX N/A
- CAPT N/A
- EPS Growth
- SCYX N/A
- CAPT N/A
- EPS
- SCYX N/A
- CAPT N/A
- Revenue
- SCYX $3,257,000.00
- CAPT $17,389,944.00
- Revenue This Year
- SCYX $422.61
- CAPT N/A
- Revenue Next Year
- SCYX $240.56
- CAPT N/A
- P/E Ratio
- SCYX N/A
- CAPT N/A
- Revenue Growth
- SCYX N/A
- CAPT 84.70
- 52 Week Low
- SCYX $0.66
- CAPT $0.37
- 52 Week High
- SCYX $1.66
- CAPT $2.60
- Technical
- Relative Strength Index (RSI)
- SCYX 54.46
- CAPT 53.87
- Support Level
- SCYX $0.82
- CAPT $0.92
- Resistance Level
- SCYX $0.88
- CAPT $1.34
- Average True Range (ATR)
- SCYX 0.04
- CAPT 0.08
- MACD
- SCYX -0.00
- CAPT 0.01
- Stochastic Oscillator
- SCYX 48.45
- CAPT 95.00
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.